CLINICAL REPORT |
Postexposure Prophylaxis in Children and Adolescents for Nonoccupational Exposure to Human Immunodeficiency Virus
Exposure to human immunodeficiency virus (HIV) can occur in a number of situations unique to, or more common among, children and adolescents. Guidelines for postexposure prophylaxis (PEP) for occupational and nonoccupational (eg, sexual, needle-sharing) exposures to HIV have been published by the US Public Health Service, but they do not directly address nonoccupational HIV exposures unique to children (such as accidental exposure to human milk from a woman infected with HIV or a puncture wound from a discarded needle on a playground), and they do not provide antiretroviral drug information relevant to PEP in children.
This clinical report reviews issues of potential exposure of children and adolescents to HIV and gives recommendations for PEP in those situations. The risk of HIV transmission from nonoccupational, nonperinatal exposure is generally low. Transmission risk is modified by factors related to the source and extent of exposure. Determination of the HIV infection status of the exposure source may not be possible, and data on transmission risk by exposure type may not exist. Except in the setting of perinatal transmission, no studies have demonstrated the safety and efficacy of postexposure use of antiretroviral drugs for the prevention of HIV transmission in nonoccupational settings. Antiretroviral therapy used for PEP is associated with significant toxicity. The decision to initiate prophylaxis needs to be made in consultation with the patient, the family, and a clinician with experience in treatment of persons with HIV infection. If instituted, therapy should be started as soon as possible after an exposure—no later than 72 hours—and continued for 28 days. Many clinicians would use 3 drugs for PEP regimens, although 2 drugs may be considered in certain circumstances. Instruction for avoiding secondary transmission should be given. Careful follow-up is needed for psychologic support, encouragement of medication adherence, toxicity monitoring, and serial HIV antibody testing.
Abbreviations: HIV, human immunodeficiency virus • USPHS, US Public Health Service • PEP, postexposure prophylaxis • CDC, Centers for Disease Control and Prevention • CI, confidence interval • AIDS, acquired immunodeficiency syndrome • PI, protease inhibitor • NRTI, nucleoside analog reverse transcriptase inhibitor • PCR, polymerase chain reaction • ZDV, zidovudine
CiteULike 
Connotea 
Del.icio.us 
Digg 
Facebook 
Reddit 
Technorati 
Twitter What's this?
Statements of reaffirmation:
-
AAP Publications Reaffirmed, January 2007
Pediatrics 119: 1031-1031.[Full Text]
-
AAP Publications Retired and Reaffirmed
Pediatrics 123: 188-188.[Full Text]
This article has been cited by other articles:
|
|
 |
|
  E. P. Simpkins, G. K. Siberry, and N. Hutton Thinking About HIV Infection Pediatr. Rev., September 1, 2009; 30(9): 337 - 349. [Full Text] [PDF]
|
|
|
|
 |
|
 Injuries From Discarded Needles in the Community Red Book, January 1, 2009; 2009(1): 184 - 187. [Full Text]
|
|
|
|
|
|
Human Immunodeficiency Virus Infection Red Book, January 1, 2009; 2009(1): 380a - 400a. [Full Text]
|
|
|
|
|
|
Occupational Health Red Book, January 1, 2009; 2009(1): 158 - 159. [Full Text]
|
|
|
|
 |
|
 M. Kaufman and and the Committee on Adolescence Care of the Adolescent Sexual Assault Victim Pediatrics, August 1, 2008; 122(2): 462 - 470. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Papenburg, D. Blais, D. Moore, M. Al-Hosni, C. Laferriere, B. Tapiero, and C. Quach Pediatric Injuries From Needles Discarded in the Community: Epidemiology and Risk of Seroconversion Pediatrics, August 1, 2008; 122(2): e487 - e492. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. C. Merchant, E. T. Kelly, K. H. Mayer, B. M. Becker, S. J. Duffy, and D. L. Pugatch Compliance in Rhode Island Emergency Departments With American Academy of Pediatrics Recommendations for Adolescent Sexual Assaults Pediatrics, June 1, 2008; 121(6): e1660 - e1667. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Ellen Human Immunodeficiency Virus Prophylaxis for Sexual Assault Survivors: What We Need to Know Arch Pediatr Adolesc Med, July 1, 2006; 160(7): 754 - 755. [Full Text] [PDF]
|
|
|
|
|
|
Committee on Pediatric AIDS Reducing the Risk of HIV Infection Associated With Illicit Drug Use Pediatrics, February 1, 2006; 117(2): 566 - 571. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Injuries From Discarded Needles in the Community Red Book, January 1, 2006; 2006(1): 188 - 191. [Full Text]
|
|
|
|
|
|
Human Immunodeficiency Virus Infection Red Book, January 1, 2006; 2006(1): 378 - 401. [Full Text]
|
|
|
|
|
|
Occupational Health Red Book, January 1, 2006; 2006(1): 160 - 162. [Full Text]
|
|
|
|
 |
|
 J C Ellis, S Ahmad, and E M Molyneux Introduction of HIV post-exposure prophylaxis for sexually abused children in Malawi Arch. Dis. Child., December 1, 2005; 90(12): 1297 - 1299. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J L Derrick, C D Gomersall, N V Makwana, and F A I Riordan Community needlestick injuries may still be dangerous * Author's reply Arch. Dis. Child., November 1, 2005; 90(11): 1204 - 1205. [Full Text] [PDF]
|
|
|
|
 |
|
 J. Stockheim, N. Wilkinson, and C. Ramos-Bonoan Human Bites and Blood Exposures in New York City Schools Clinical Pediatrics, October 1, 2005; 44(8): 699 - 703. [Abstract] [PDF]
|
|
|
|
|
|
N. Kellogg and and the Committee on Child Abuse and Neglect The Evaluation of Sexual Abuse in Children Pediatrics, August 1, 2005; 116(2): 506 - 512. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. O'Keefe Guidance issued on prophylaxis for kids exposed to HIV AAP News, December 1, 2003; 23(6): 297 - 297. [Full Text] [PDF]
|
|
